Oramed Enrolls First Patient in Its Glucose Clamp Study for Oral Insulin

Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today it has enrolled the first patient in its Glucose Clamp Study which will quantify insulin absorption in type 1 d https://www.biospace.com/article/releases/oramed-enrolls-first-patient-in-its-glucose-clamp-study-for-oral-insulin/